TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Takara Bio Inc. ( (JP:4974) ) has provided an announcement.
Takara Bio Inc. has announced its relationship with its parent company, Takara Holdings Inc., highlighting its operational independence within the group. Despite being part of a larger corporate structure, Takara Bio Inc. maintains autonomy in its business operations, reporting to Takara Holdings Inc. without requiring prior approval for board resolutions. This structure aims to maximize corporate value while ensuring the company’s growth and independence.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen830.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc. is a company specializing in the biotechnology industry, operating as a subsidiary within the Takara Holdings Group. The company focuses on biotechnology products and services, leveraging its position within a larger group of 70 companies, including 68 subsidiaries and two affiliates, to enhance growth and competitiveness in its sector.
Average Trading Volume: 228,946
Technical Sentiment Signal: Sell
Current Market Cap: Yen94.17B
See more insights into 4974 stock on TipRanks’ Stock Analysis page.